Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

A common cough syrup, Ambroxol, has shown potential in slowing the progression of Parkinson's dementia in a recent clinical trial.

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

A cough medicine used for decades in Europe called ambroxol has shown promise for treating dementia in people with ...

A landmark study by London researchers investigating the use of a cough medicine called Ambroxo to slow the progression of ...

Mumbai: Malwani police on Tuesday arrested two men and seized 710 bottles of unprescribed codeine-laced cough syrup worth ...

Mumbai police arrested two men, Rizwan Ansari and Naved Batatawala, in Malwani for possessing 710 bottles of cough syrup ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s disease, a new study suggests. Nearly half of those diagnosed with ...

Lack of testing accounts for the highest number of patients lost in the TB care cascade, and stigma keeps many patients from ...